LU71047A1 - - Google Patents
Info
- Publication number
- LU71047A1 LU71047A1 LU71047A LU71047A LU71047A1 LU 71047 A1 LU71047 A1 LU 71047A1 LU 71047 A LU71047 A LU 71047A LU 71047 A LU71047 A LU 71047A LU 71047 A1 LU71047 A1 LU 71047A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU71047A LU71047A1 (fi) | 1974-10-03 | 1974-10-03 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| LU71047A LU71047A1 (fi) | 1974-10-03 | 1974-10-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU71047A1 true LU71047A1 (fi) | 1975-06-24 |
Family
ID=19727761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU71047A LU71047A1 (fi) | 1974-10-03 | 1974-10-03 |
Country Status (1)
| Country | Link |
|---|---|
| LU (1) | LU71047A1 (fi) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0195496A2 (en) * | 1985-01-21 | 1986-09-24 | Beecham Group Plc | Use of xanthines in the treatment of proliferative skin disease |
| EP0232438A1 (en) * | 1984-04-30 | 1987-08-19 | Hoechst-Roussel Pharmaceuticals Incorporated | Use of xanthine derivatives for host defense mechanism enhancement |
| EP0430025A2 (en) * | 1989-11-24 | 1991-06-05 | Hokuriku Pharmaceutical Co., Ltd. | Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same |
| EP0570831A2 (de) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation |
-
1974
- 1974-10-03 LU LU71047A patent/LU71047A1/xx unknown
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0232438A1 (en) * | 1984-04-30 | 1987-08-19 | Hoechst-Roussel Pharmaceuticals Incorporated | Use of xanthine derivatives for host defense mechanism enhancement |
| EP0195496A2 (en) * | 1985-01-21 | 1986-09-24 | Beecham Group Plc | Use of xanthines in the treatment of proliferative skin disease |
| EP0195496A3 (en) * | 1985-01-21 | 1990-01-17 | Beecham Group Plc | Use of xanthines in the treatment of proliferative skin disease |
| EP0430025A2 (en) * | 1989-11-24 | 1991-06-05 | Hokuriku Pharmaceutical Co., Ltd. | Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same |
| EP0430025A3 (en) * | 1989-11-24 | 1992-05-06 | Hokuriku Pharmaceutical Co., Ltd. | Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same |
| EP0570831A2 (de) * | 1992-05-20 | 1993-11-24 | Hoechst Aktiengesellschaft | Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation |
| EP0570831A3 (fi) * | 1992-05-20 | 1994-03-16 | Hoechst Ag |